Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma, Ewing × efineptakin alfa × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Carcinoma 1

Interventions

Temozolomide 12 Vincristine 8 Irinotecan 8 Cyclophosphamide 7 Etoposide 5 cabozantinib 4 X-Rays 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Ifosfamide 4 Doxorubicin 4 regorafenib 3 fludarabine 3 Radiotherapy 3 Radiation 3 Phantoms, Imaging 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 olaparib 2 liposomal doxorubicin 2 ivosidenib 2 irinotecan sucrosofate 2 etoposide phosphate 2 abemaciclib 2 Zoledronic Acid 2 Topotecan 2 Surgical Procedures, Operative 2 Sirolimus 2 Radiotherapy, Image-Guided 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡